Highly CORRUPT FDA and CDC still pretending the PLANDEMIC is happening to inject children under 5 with “emergency authorization” clot shots

No, the clot shots were never really approved for use on humans. The proper protocol was circumvented, and now Google even added mRNA to the definition of vaccines, since the clot shots don’t even fit the definition. It was all declared an “emergency,” but the plandemic has been over for some time, yet somehow the FDA and CDC are still injecting kids with their EUA blood-clogging jabs.

The U.S. Food and Drug Administration (FDA) is reportedly considering rescinding the emergency use authorization (EUA) for Pfizer’s COVID-19 vaccine for children under 5, a shot available under EUA since June 2022 but never fully approved. According to The New York Times and The Guardian, the news came via an email from the Centers for Disease Control and Prevention (CDC) to state and local health departments. While Pfizer’s shot for children aged 5–11 remains under EUA, full approval for that group is expected this fall. The FDA may also move toward fully licensing Pfizer’s vaccine for adolescents 12 and older.

• The FDA is reportedly considering ending the emergency use authorization (EUA) for Pfizer’s COVID-19 vaccine for children under 5, while moving toward full approval for the 5–11 age group this fall; the CDC informed state and local health departments of the potential change, though HHS has not confirmed it.
• Pfizer’s pediatric vaccine for children under 5 has been available under EUA since June 2022 but never fully approved; if rescinded, no COVID-19 vaccine would be authorized for healthy children under 5, though Moderna’s shot could be prescribed “off label.”
• Critics, including pediatrician Dr. Michelle Perro, cite safety concerns and minimal COVID-19 risk for young children, arguing that mRNA vaccines for this age group offer no benefit and carry documented risks such as myocarditis, seizures, and neurological harms.
• Vaccination rates for young children remain low (5.6% for ages 6 months–5 years, ~15% for ages 5–17), and the CDC has shifted from universal COVID-19 vaccination recommendations for healthy children to a “shared clinical decision-making” approach with parents and providers.

FDA may end Pfizer’s COVID-19 vaccine authorization for young children as CDC shifts recommendations

The U.S. Department of Health and Human Services (HHS) has declined to confirm these reports, calling any discussion of future regulatory changes “speculation.” Pfizer has acknowledged discussions with the FDA, noting that the possible withdrawal of authorization is unrelated to safety or efficacy concerns. The company has requested the EUA be extended through the 2025–2026 season.

If the EUA for Pfizer’s youngest age group is withdrawn, it would follow the FDA’s recent move to fully approve Moderna’s Spikevax for children ages six months to 11 years, but only for those with underlying health conditions. Novavax’s COVID-19 vaccine remains available only for older and high-risk populations. The Guardian reported that Moderna may increase pediatric vaccine supply amid concerns that the FDA’s potential decision could limit access.

Despite authorization, uptake among children has been low. CDC data show only 5.6 percent of children ages 6 months–5 years and 15 percent of children ages 5–17 have received COVID-19 vaccines. Some physicians, such as pediatrician Dr. Michelle Perro, argue strongly for rescinding the EUA, citing negligible COVID-19 risk for healthy children and pointing to reported adverse effects, including myocarditis and seizures. Critics contend the vaccines offer no meaningful benefit for this demographic and pose ethical concerns.

A regulatory change would align with the CDC’s May 2025 decision to remove the recommendation for COVID-19 vaccination in healthy children. The agency now advises “shared clinical decision-making” between parents and healthcare providers for children ages 6 months–17 years who are not moderately immunocompromised. Without the Pfizer EUA, there would be no authorized COVID-19 vaccine for healthy children under 5, though doctors could prescribe Moderna’s vaccine off-label at parental request.

CDC scientists have maintained that healthy young children face significant COVID-19 risks, citing 16 deaths among children ages 2–4 between July 2024 and June 2025. However, experts on both sides dispute the necessity of vaccinating healthy children, with opponents emphasizing potential autoimmune and inflammatory complications.

Legal challenges have also targeted pediatric COVID-19 vaccine authorizations. In 2022, Children’s Health Defense sued the FDA over its EUA decisions, alleging misuse of emergency powers—a case ultimately rejected by the U.S. Supreme Court.

The FDA first authorized COVID-19 vaccines for ages 16+ in late 2020, expanded to 12-year-olds in May 2021, to 5–11-year-olds in October 2021, and to children 6 months and older in June 2022. In early 2023, the CDC incorporated COVID-19 vaccines into its standard immunization schedules, recommending annual boosters until altering guidance in 2025. Recently, the FDA has implemented stricter approval requirements for future COVID-19 vaccines, reflecting a more cautious regulatory stance moving forward.

Bookmark Vaccines.news to get the latest updates about the emergency authorized death jabs that were NEVER TESTED for safety or efficacy, yet somehow are STILL authorized like there’s a pandemic underway and little babies must get jabbed for population reduction reasons.

Sources for this article include:

ChildrensHealthDefense.org

TheHill.com

NEJM.org

NaturalNews.com